Skip to main content
. 2012 May 1;12(14):1–62.
Figure 1: Randomization Scheme for Cohort A
Figure 2: Death and Adverse Events at 30 Days (ITT), TAVI vs. sAVRa
Figure 3: Death and Adverse Events at 1 Year (ITT), TAVI vs. sAVRa
Figure 4: Death and Adverse Events at 30 Days (ITT), TF TAVI vs. sAVRa
Figure 5: Death and Adverse Events at 1 Year (ITT), TF TAVI vs. sAVRa
Figure 6: Death and Adverse Events at 30 Days (ITT), TA TAVI vs. sAVRa
Figure 7: Death and Adverse Events at 1 Year (ITT), TA TAVI vs. sAVRa
Figure 8: Mortality Rates at 30 Days
Figure 9: Mortality Rates at 1 Year
Figure 10: Rate of Stroke/TIA at 30 Days
Figure 11: Rate of Stroke/TIA at 1 Year
Figure 12: Rates of Complications at 30 Days
Figure 13: Rates of Complications at 1 Year
Figure 14: 30-Day Postoperative Decision Tree
Figure 15: Long-Term Markov Model
Figure A1: Death and Adverse Events at 30 Days, TAVI vs. sAVRa
Figure A2: Death and Adverse Events at 1 Year, TAVI vs. sAVRa
Figure A3: Death and Adverse Events at 30 Days, TF TAVI vs. sAVRa
Figure A4: Death and Adverse Events at 1 Year, TF TAVI vs. sAVRa
Figure A5: Death and Adverse Events at 30 Days, TA TAVI vs. sAVRa
Figure A6: Death and Adverse Events at 1 Year, TA TAVI vs. sAVRa